European Pharmaceutical Review

AUGUST 23, 2022

FAKE MEDICINES are not a new problem, and pose a tremendous threat to patient safety and public health in society regardless of a country’s economic status. Unfortunately, such a chain of custody is not intended to provide patients with the ability to verify their own medicines. About the author. Available from: [link].

Medicine 89

Medicine Food and Drug Administration Pharmaceutical products Pharmaceutical 89

Evolve Your Success

MAY 10, 2022

In a world of medical and health jargon, it can be difficult for patients to understand the kind of care they are getting. Sometimes, beyond the language, it is in the way health professionals communicate to the patient and their families as well as to each other. They are also patient advocates from their experience in nursing.

Education 52

Education Patients Medical sales reps Medical sales 52

European Pharmaceutical Review

JULY 13, 2023

1,2 Moreover, except for countries such as Czechia, Denmark and Germany, the cost of these medications is borne by the patient, rather than national insurance or healthcare systems. This will lead to a higher proportion of these medicines becoming licensed, benefitting a larger number of patients.

Medical 83

Medical Food and Drug Administration Pharmacology Medicine 83

European Pharmaceutical Review

DECEMBER 19, 2022

3 Under this pathway, comparability studies are required to substantiate the similar nature, in terms of safety and efficacy, of the biosimilar and the reference product. For this reason, a unique ‘abridged’ procedure was introduced to provide a specific regulatory pathway for biosimilars in the EU.

Medicine 52

Medicine Biopharma Safety Food 52

pharmaphorum

NOVEMBER 9, 2022

The present moment within and without healthcare, biotech, and pharma is a difficult and pivotal time in history, a time in which such issues need must be addressed. The keynote address of the event entire came from Stella Kyriakides, commissioner for health and food safety at the European Commission. Her opener?

Insurance 88

Insurance Patients Healthcare Healthcare 88

European Pharmaceutical Review

DECEMBER 21, 2022

Despite the tidal wave of renewed interest in psychedelic therapies, there is still much to be learned about them, including their precise mechanisms of action, their long- and short-term safety profiles, the durability of their effect, and their adverse effects—which can be severe. Authorisation under exceptional circumstances.

Food and Drug Administration 106

Food and Drug Administration Medicine Food Government 106

European Pharmaceutical Review

JUNE 27, 2023

Hervé Affagard (HA): Developing microbiome therapeutics as well as every other new therapeutic modality comes with several challenges that need to be addressed carefully to ensure patient safety and maximise the potential benefits of these treatments. The sheer volume of microbiome studies is another key trend.

Food and Drug Administration 96

Food and Drug Administration Manufacturing Medicine Pharma 96

European Pharmaceutical Review

DECEMBER 19, 2023

A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient. About 800 million humans are injected with vaccines every year” Most vaccines in use today are relatively cheap to make and are injected into patients with mass‑produced and inexpensive (five-cent) disposable syringes.

Distribution 98

Distribution Manufacturing Food Specialization 98

Evolve Your Success

FEBRUARY 6, 2024

Mark discusses the role of value analysis in improving their products and services, allowing them to properly address the ever-changing and specific needs of patients. Mark Copeland has an experience in medical device sales with 18 years in the game and 27 in healthcare. He brings new products that solve healthcare problems.

Medical sales 59

Medical sales Medical Sales Doctors 59

Clarify Health

MARCH 15, 2023

The challenges are universal in that we still need to get to a place where providers look at this as a partnership where we all come together for the benefit of the patient. Everything is headbutting, and it’s a hard thing for both sides to come together and say, “Yes, but now we got to focus on the patient.”

Management 52

Management Patients Physicians Government 52

European Pharmaceutical Review

FEBRUARY 7, 2023

Regulation of clinical trials Eight years following its adoption in 2014, the Clinical Trials Regulation 536/2014 (CTR) entered into application on 31 January 2022. In addition, the devices must not present an unacceptable risk to patient and user health and safety as established in Articles 94 and 95 of the MDR.

Government 92

Government Medical Medicine Marketing 92

European Pharmaceutical Review

FEBRUARY 22, 2023

Although effective, the inconvenience of regular injections can lead to poor patient adherence, with studies showing that persistence and adherence are generally better for oral medications compared with injections. We can see a future where millions of patients no longer carry the burden of regular injections.”

Food and Drug Administration 87

Food and Drug Administration Manufacturing Safety Pharmaceutical 87

Cadensee

JULY 26, 2021

Until back in 2014, I met the team at Schneider Children's Medical Center of Israel. And I was lucky enough the team at Schneider's and Clalit Healthcare , who is the owner of Schneider Hospital. it's the only reason that it was possible, because this was a hospital and they had access to the resources and the patients.

Retail 52

Retail Marketing Doctors Food 52

Pharmaceutical Technology

FEBRUARY 6, 2023

The FDA approved both drugs in 2014. In an email , a Pliant spokesperson told Pharmaceutical Technology , “As currently approved therapies are not well tolerated, a new agent with a favorable safety profile and demonstrated efficacy would be a welcome addition to the IPF treatment armamentarium”.

Marketing 59

Marketing Pharmaceutical FDA Prospecting 59